Renal profile of chronic hepatitis C patients with sofosbuvir-based therapy.

Mohammad El-SayedZeinab AbdellatifAisha ElsharkawyMohamed El KassasReham Abd ElmoniemAmaal MarzoukRabab FouadGamal EsmatShereen Abdel Alem

Published in: Infection (2020)

SOF-based therapies seem to be safe in CHC patients with baseline normal or slightly impaired renal function.

Keyphrases